Suspension of trading
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret Share Price
Equities
ECILC
TRAECILC91E0
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.10 TRY | -0.71% |
|
-2.43% | +37.16% |
| 03-03 | Eis Eczacibasi FY net profit up at 2.09 bln lira YoY | RE |
| 02-04 | EIS Eczacibasi Ilac says unit Gensenta to cease all production at Sekerpinar facility | RE |
| Capitalization | 56.05B 1.27B 1.1B 998M 958M 1.75B 117B 1.82B 11.8B 4.72B 4.78B 4.68B 201B | P/E ratio 2023 |
11x | P/E ratio 2024 | 31.9x |
|---|---|---|---|---|---|
| Enterprise value | 56.57B 1.29B 1.11B 1.01B 967M 1.76B 118B 1.84B 11.91B 4.76B 4.83B 4.72B 203B | EV / Sales 2023 |
4.78x | EV / Sales 2024 | 3.78x |
| Free-Float |
18.77% | Yield 2023 |
2.68% | Yield 2024 | 3.68% |
| 1 day | -0.97% | ||
| 1 week | -2.78% | ||
| Current month | -2.78% | ||
| 1 month | +3.52% | ||
| 3 months | +24.43% | ||
| 6 months | +96.31% | ||
| Current year | +36.67% |
| 1 week | 105.4 |  | 116.6 |
| 1 month | 105.4 | | 132.2 |
| Current year | 82 | | 132.6 |
| 1 year | 37.92 | | 132.6 |
| 3 years | 24.34 | | 132.6 |
| 5 years | 5.66 | | 132.6 |
| 10 years | 2.14 | | 132.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emin Fadillioglu
CEO | Chief Executive Officer | - | 31/08/2022 |
| Corporate Officer/Principal | - | - | |
| Corporate Officer/Principal | 42 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 02/04/1981 | |
| Director/Board Member | 72 | 30/03/1993 | |
| Director/Board Member | 59 | 11/04/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.58% | 0% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.80% | -2.78% | +148.33% | +252.02% | 1.76B | |
| -2.02% | -3.79% | +5.76% | +208.78% | 878B | |
| -2.31% | -1.58% | +45.12% | +55.58% | 577B | |
| -1.63% | +3.41% | +9.84% | +48.89% | 411B | |
| -2.87% | -7.14% | +12.59% | +25.90% | 359B | |
| -0.41% | -5.42% | +22.21% | +36.84% | 305B | |
| -1.53% | -5.89% | +23.47% | +55.04% | 304B | |
| -3.50% | -2.71% | +24.55% | +8.60% | 287B | |
| -3.08% | -3.09% | +16.12% | +56.55% | 198B | |
| -2.08% | +0.95% | +25.73% | +79.03% | 180B | |
| Average | -1.48% | -1.53% | +33.37% | +82.72% | 350.13B | |
| Weighted average by Cap. | -1.19% | -1.65% | +19.63% | +86.02% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 6.48B 147M 127M 115M 111M 202M 13.52B 211M 1.36B 545M 553M 541M 23.23B | 8.77B 199M 172M 156M 150M 273M 18.3B 285M 1.85B 738M 748M 732M 31.44B |
| Net income | 2.74B 62.27M 53.85M 48.76M 46.82M 85.39M 5.72B 89.15M 577M 231M 234M 229M 9.82B | 1.02B 23.26M 20.12M 18.22M 17.49M 31.9M 2.14B 33.31M 216M 86.13M 87.31M 85.45M 3.67B |
| Net Debt | 862M 19.59M 16.94M 15.34M 14.73M 26.86M 1.8B 28.04M 181M 72.51M 73.51M 71.94M 3.09B | 513M 11.66M 10.08M 9.13M 8.76M 15.98M 1.07B 16.69M 108M 43.15M 43.75M 42.81M 1.84B |
Employees
1,096
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 112.10 ₺ | -0.71% | 1,300,971 |
| 05/03/26 | 112.90 ₺ | -0.96% | 2,681,870 |
| 04/03/26 | 114.00 ₺ | +1.88% | 2,793,580 |
| 03/03/26 | 111.90 ₺ | -0.27% | 2,648,362 |
| 02/03/26 | 112.20 ₺ | -2.43% | 3,916,637 |
- Stock Market
- Equities
- ECILC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition